Basic Information
Basic information for ZNF503-AS1-217-10aa-2
Peptide Name ZNF503-AS1-217-10aa-2
Genome Position chr10:75361115-75361144[+]
Species Human
Peptide Sequence MGFAGREVQL
Peptide Length 10
Unique No (ZNF503-AS1-201-10aa,ZNF503-AS1-203-10aa,ZNF503-AS1-204-10aa,ZNF503-AS1-208-10aa,ZNF503-AS1-210-10aa,ZNF503-AS1-211-10aa-1,ZNF503-AS1-212-10aa,ZNF503-AS1-213-10aa,ZNF503-AS1-215-10aa,ZNF503-AS1-218-10aa,ZNF503-AS1-219-10aa,ZNF503-AS1-220-10aa,ZNF503-AS1-221-10aa,ZNF503-AS1-222-10aa,ZNF503-AS1-223-10aa,ZNF503-AS1-224-10aa,ZNF503-AS1-225-10aa)
Grand Average of Hydropathicity 0.22
Relative Molecular Mass 1269.43
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000226051;ZNF503-AS1
Transcript ID/Name ENST00000665971;ZNF503-AS1-217
Transcript Length 1637
Coding Ability 0.3574
DNA Sequence Corresponding to Peptide ATGGGCTTTGCAGGCAGGGAGGTCCAGTTA
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :